[HTML][HTML] Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - PLoS …, 2021 - journals.plos.org
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalization among Finnish elderly and chronically ill–An interim analysis of a nationwide …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - medRxiv, 2021 - medrxiv.org
Abstract Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19
vaccines have been used after the vaccination campaign started on December 27, 2020 …
vaccines have been used after the vaccination campaign started on December 27, 2020 …
[PDF][PDF] Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - PLoS ONE, 2021 - scienceopen.com
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
[PDF][PDF] Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - PLoS ONE, 2021 - tuhat.helsinki.fi
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide …
U Baum, EJ Poukka, A Palmu, H Salo… - PLoS …, 2021 - researchportal.helsinki.fi
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
[引用][C] Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a …
U Baum, E Poukka, AA Palmu, H Salo… - PLoS …, 2021 - ui.adsabs.harvard.edu
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation
among Finnish elderly and chronically ill—An interim analysis of a nationwide cohort study …
among Finnish elderly and chronically ill—An interim analysis of a nationwide cohort study …
[PDF][PDF] Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - 2021 - julkari.fi
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
[PDF][PDF] Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalization among Finnish elderly and chronically 2 ill–An interim analysis of a …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - scholar.archive.org
Abstract 23 Background 24 In Finland, both mRNA and adenovirus vector (AdV) Covid-19
vaccines have been used after the 25 vaccination campaign started on December 27, 2020 …
vaccines have been used after the 25 vaccination campaign started on December 27, 2020 …
Effectiveness of vaccination against SARS-CoV-2 infection and COVID-19 hospitalisation among Finnish elderly and chronically ill-an interim analysis of a nationwide …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - 2021 - cabidigitallibrary.org
Abstract Background: In Finland, both mRNA and adenovirus vector (AdV) Covid-19
vaccines have been used after the vaccination campaign started on December 27, 2020 …
vaccines have been used after the vaccination campaign started on December 27, 2020 …
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - PLoS ONE, 2021 - go.gale.com
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …